McDonald Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
McDonald Partners's PFE Position: Q1 2026 in Review
McDonald Partners increased its Pfizer (PFE) stake by 8.1% in Q1 2026, buying an estimated $206K and bringing the position to 102,552 shares worth $2.88M. The position accounts for 0.68% of the portfolio, ranked #46.
McDonald Partners first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $6.4M in Q2 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- McDonald Partners held 102,552 shares of Pfizer worth $2.88M as of Q1 2026.
- McDonald Partners bought 7,726 Pfizer shares in Q1 2026, an estimated $206K.
- Pfizer made up 0.68% of McDonald Partners's portfolio in Q1 2026, its #46 holding.
- McDonald Partners first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- McDonald Partners's Pfizer position peaked at $6.4M in Q2 2022.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on McDonald Partners's 13F filing for Q1 2026, filed 15 May 2026.